Also trades as: HTGM (NASDAQ) · $vol 0M
HTGMQ OTC
HTG Molecular Diagnostics, Inc.
1W: +0.0%
1M: +9900.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -99.6%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$18M
-11.5% ▼
Capital Expenditures
$23K
+96.4% ▲
5Y CAGR: -53.1%
Free Cash Flow
-$18M
-7.5% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$3M
+120.4% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$16M | -$19M | -$21M | -$17M | -$22M |
| Depreciation & Amort. | $1M | $1M | $1M | $721K | $587K |
| Stock-Based Comp. | $2M | $1M | $2M | $1M | $815K |
| Change in Working Capital | $25K | -$486K | -$157K | -$990K | -$143K |
| Other Non-Cash Items | -$160K | $605K | $896K | -$470K | $2M |
| Operating Cash Flow | -$13M | -$17M | -$16M | -$17M | -$18M |
| — Investing Activities — | |||||
| Capital Expenditures | -$950K | -$1M | -$454K | -$644K | -$23K |
| Acquisitions (Net) | $0 | $2K | -$19K | $6K | $0 |
| Investment Purchases | -$54M | -$35M | -$12M | -$19M | -$8M |
| Investment Sales | $32M | $32M | $32M | $13M | $20M |
| Other Investing | $0 | -$2K | $19K | -$6K | $104K |
| Investing Cash Flow | -$23M | -$4M | $19M | -$7M | $12M |
| — Financing Activities — | |||||
| Net Debt Issuance | $976K | -$44K | $667K | -$766K | -$7M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$1M | -$1M | $274K | $492K | $16M |
| Financing Cash Flow | $38M | $19M | $9M | $10M | $9M |
| Net Change in Cash | $2M | -$813K | $12M | -$13M | $3M |
| Cash End of Period | $12M | $11M | $22M | $10M | $12M |
| Free Cash Flow | -$14M | -$18M | -$17M | -$17M | -$18M |